Table 1.
Age(years) |
|||||||
Patient | When Studied | At Diagnosis | Statusa | Total Serum Alkaline Phosphatase(×ULN)b | Radiological Features | No. of Bone Sites Affected | Total Pagetic Bonec(%) |
DD-003 | 77 | … | N | Normal | Normal | 0 | 0 |
DD-004 | 76 | 48 | + | 25.2 | Paget | 31 | 37 |
DD-019 | 73 | 70 | + | .5 | Paget | 2 | 16 |
DD-021 | 71 | 67 | + | .7 | Paget | 1 | 3 |
DD-033 | 53 | 49 | + | .5 | Paget | 4 | 5 |
TH-019 | 55 | 43 | + | 1.0 | Paget | 3 | 7 |
TH-102 | 64 | 60 | + | 1.6 | Paget | 15 | 53 |
TH-111 | 83 | 58 | + | 20.3 | Paget | 14 | 64 |
TH-143 | 52 | 46 | + | 11.8 | Paget | 26 | 31 |
LF-010 | 57 | 54 | + | 1.0 | Paget | 6 | 20 |
LF-019 | 80 | … | N | Normal | Normal | 0 | 0 |
LF-045 | 78 | 68 | + | 3.7 | Paget | 7 | 36 |
LF-074 | 74 | 46 | + | 4.4 | Paget | 16 | 64 |
As described in the Patients, Material, and Methods section. N = normal; + = Paget disease of bone.
ULN = upper limit of normal range, as determined by each clinical laboratory.
Calculated by use of Rénier et al.'s (1995) index.